Miracle Mile Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Miracle Mile Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,047	Closed	-$1.12M	–	467
2022 Q2	$1.12M	Buy	+15,047	New	+$1.13M	0.05%	212
2020 Q1	–	Sell	-2,244	Closed	-$213K	–	322
2019 Q4	$213K	Buy	+2,244	New	+$194K	0.01%	279
2019 Q2	–	Sell	-2,292	Closed	-$208K	–	288
2019 Q1	$208K	Buy	+2,292	New	+$195K	0.02%	247
2018 Q4	–	Sell	-2,244	Closed	-$215K	–	191
2018 Q3	$215K	Sell	2,244 -395	-15%	-$38.3K	0.02%	156
2018 Q2	$251K	Buy	+2,639	New	+$243K	0.02%	139
2018 Q1	–	Sell	-2,460	Closed	-$209K	–	160
2017 Q4	$209K	Buy	+2,460	New	+$206K	0.03%	96
2016 Q2	–	Sell	-5,895	Closed	-$305K	–	71
2016 Q1	$305K	Sell	5,895 -1,920	-25%	-$99.7K	0.11%	42
2015 Q4	$549K	Buy	7,815 +1,920	+33%	+$131K	0.2%	31
2015 Q3	$367K	Buy	+5,895	New	+$465K	0.12%	39

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Miracle Mile Advisors's XBI Position: Q3 2022 in Review

Miracle Mile Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 15,047 shares — an estimated $1.12M sold.

Miracle Mile Advisors first reported a position in XBI in Q3 2015 and held it in 9 quarters. The position peaked at $1.12M in Q2 2022. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Miracle Mile Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Miracle Mile Advisors sold 15,047 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $1.12M.
Miracle Mile Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 9 quarters.
Miracle Mile Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.12M in Q2 2022.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Miracle Mile Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.